Listed

Sanara MedTech Inc.

SMTINasdaqCIK 714256HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$28.1m, Q2 FY2026
Operating income$1.8m, Q2 FY2026
Net income−$452.9k, Q2 FY2026
Sanara MedTech Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m16.0Revenue, Q3 FY2023, three months to 2023-09-30$16.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-12, accession 0001493152-24-044737.Report this figure17.7Revenue, Q4 FY2023, three months to 2023-12-31$17.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-25, accession 0001641172-25-000632. Derived: 12-month figure less the 9-month figure.Report this figure18.5Revenue, Q1 FY2024, three months to 2024-03-31$18.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-14, accession 0001641172-25-010254.Report this figure20.2Revenue, Q2 FY2024, three months to 2024-06-30$20.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-13, accession 0001493152-25-011885.Report this figure21.7Revenue, Q3 FY2024, three months to 2024-09-30$21.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001493152-25-021894.Report this figure26.3Revenue, Q4 FY2024, three months to 2024-12-31$26.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-24, accession 0001493152-26-012352. Derived: 12-month figure less the 9-month figure.Report this figure23.4Revenue, Q1 FY2025, three months to 2025-03-31$23.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-12, accession 0001493152-26-022479.Report this figure25.8Revenue, Q2 FY2025, three months to 2025-06-30$25.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001493152-26-037176.Report this figure26.3Revenue, Q3 FY2025, three months to 2025-09-30$26.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001493152-25-021894.Report this figure27.5Revenue, Q4 FY2025, three months to 2025-12-31$27.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-24, accession 0001493152-26-012352. Derived: 12-month figure less the 9-month figure.Report this figure27.8Revenue, Q1 FY2026, three months to 2026-03-31$27.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-12, accession 0001493152-26-022479.Report this figure28.1Revenue, Q2 FY2026, three months to 2026-06-30$28.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001493152-26-037176.Report this figure
Cost of revenue$m1.8Cost of revenue, Q3 FY2023, three months to 2023-09-30$1.8m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2024-11-12, accession 0001493152-24-044737.Report this figure1.8Cost of revenue, Q4 FY2023, three months to 2023-12-31$1.8m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2025-03-25, accession 0001641172-25-000632. Derived: 12-month figure less the 9-month figure.Report this figure1.9Cost of revenue, Q1 FY2024, three months to 2024-03-31$1.9m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-05-14, accession 0001641172-25-010254.Report this figure2.0Cost of revenue, Q2 FY2024, three months to 2024-06-30$2.0m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-08-13, accession 0001493152-25-011885.Report this figure2.0Cost of revenue, Q3 FY2024, three months to 2024-09-30$2.0m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-12, accession 0001493152-25-021894.Report this figure2.2Cost of revenue, Q4 FY2024, three months to 2024-12-31$2.2m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-03-24, accession 0001493152-26-012352. Derived: 12-month figure less the 9-month figure.Report this figure1.8Cost of revenue, Q1 FY2025, three months to 2025-03-31$1.8m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-12, accession 0001493152-26-022479.Report this figure1.9Cost of revenue, Q2 FY2025, three months to 2025-06-30$1.9m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-11, accession 0001493152-26-037176.Report this figure1.9Cost of revenue, Q3 FY2025, three months to 2025-09-30$1.9m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-12, accession 0001493152-25-021894.Report this figure1.9Cost of revenue, Q4 FY2025, three months to 2025-12-31$1.9m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-03-24, accession 0001493152-26-012352. Derived: 12-month figure less the 9-month figure.Report this figure1.9Cost of revenue, Q1 FY2026, three months to 2026-03-31$1.9m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-12, accession 0001493152-26-022479.Report this figure2.0Cost of revenue, Q2 FY2026, three months to 2026-06-30$2.0m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-11, accession 0001493152-26-037176.Report this figure
Gross profit$m14.3Gross profit, Q3 FY2023, three months to 2023-09-30$14.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-12, accession 0001493152-24-044737.Report this figure15.9Gross profit, Q4 FY2023, three months to 2023-12-31$15.9m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-25, accession 0001641172-25-000632. Derived: 12-month figure less the 9-month figure.Report this figure16.6Gross profit, Q1 FY2024, three months to 2024-03-31$16.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-14, accession 0001641172-25-010254.Report this figure18.2Gross profit, Q2 FY2024, three months to 2024-06-30$18.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-13, accession 0001493152-25-011885.Report this figure19.7Gross profit, Q3 FY2024, three months to 2024-09-30$19.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-12, accession 0001493152-25-021894.Report this figure24.1Gross profit, Q4 FY2024, three months to 2024-12-31$24.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-24, accession 0001493152-26-012352. Derived: 12-month figure less the 9-month figure.Report this figure21.6Gross profit, Q1 FY2025, three months to 2025-03-31$21.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-12, accession 0001493152-26-022479.Report this figure23.9Gross profit, Q2 FY2025, three months to 2025-06-30$23.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-11, accession 0001493152-26-037176.Report this figure24.5Gross profit, Q3 FY2025, three months to 2025-09-30$24.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-12, accession 0001493152-25-021894.Report this figure25.7Gross profit, Q4 FY2025, three months to 2025-12-31$25.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-24, accession 0001493152-26-012352. Derived: 12-month figure less the 9-month figure.Report this figure25.9Gross profit, Q1 FY2026, three months to 2026-03-31$25.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-12, accession 0001493152-26-022479.Report this figure26.2Gross profit, Q2 FY2026, three months to 2026-06-30$26.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-11, accession 0001493152-26-037176.Report this figure
Research and development$m1.0Research and development, Q3 FY2023, three months to 2023-09-30$986.5k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0001493152-24-044737.Report this figure0.7Research and development, Q4 FY2023, three months to 2023-12-31$651.5k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-25, accession 0001641172-25-000632. Derived: 12-month figure less the 9-month figure.Report this figure0.9Research and development, Q1 FY2024, three months to 2024-03-31$946.3k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-14, accession 0001641172-25-010254.Report this figure1.0Research and development, Q2 FY2024, three months to 2024-06-30$985.7k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-13, accession 0001493152-25-011885.Report this figure0.8Research and development, Q3 FY2024, three months to 2024-09-30$783.8k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001493152-25-021894.Report this figure0.9Research and development, Q4 FY2024, three months to 2024-12-31$883.4k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-24, accession 0001493152-26-012352. Derived: 12-month figure less the 9-month figure.Report this figure1.0Research and development, Q1 FY2025, three months to 2025-03-31$950.4k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001493152-26-022479.Report this figure1.1Research and development, Q2 FY2025, three months to 2025-06-30$1.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001493152-26-037176.Report this figure1.0Research and development, Q3 FY2025, three months to 2025-09-30$1.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001493152-25-021894.Report this figure2.0Research and development, Q4 FY2025, three months to 2025-12-31$2.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-24, accession 0001493152-26-012352. Derived: 12-month figure less the 9-month figure.Report this figure0.8Research and development, Q1 FY2026, three months to 2026-03-31$759.6k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001493152-26-022479.Report this figure1.2Research and development, Q2 FY2026, three months to 2026-06-30$1.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001493152-26-037176.Report this figure
Selling, general and administrative$m13.9Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$13.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-12, accession 0001493152-24-044737.Report this figure16.3Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$16.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2025-03-25, accession 0001641172-25-000632. Derived: 12-month figure less the 9-month figure.Report this figure16.2Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$16.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-14, accession 0001641172-25-010254.Report this figure19.0Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$19.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-13, accession 0001493152-25-011885.Report this figure17.4Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$17.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-12, accession 0001493152-25-021894.Report this figure20.2Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$20.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-24, accession 0001493152-26-012352. Derived: 12-month figure less the 9-month figure.Report this figure19.1Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$19.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-12, accession 0001493152-26-022479.Report this figure19.6Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$19.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-11, accession 0001493152-26-037176.Report this figure19.9Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$19.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-12, accession 0001493152-25-021894.Report this figure20.1Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$20.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-24, accession 0001493152-26-012352. Derived: 12-month figure less the 9-month figure.Report this figure21.9Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$21.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-12, accession 0001493152-26-022479.Report this figure22.6Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$22.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-11, accession 0001493152-26-037176.Report this figure
Operating income$m(0.9)Operating income, Q3 FY2023, three months to 2023-09-30−$906.7k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0001493152-24-044737.Report this figure(0.2)Operating income, Q4 FY2023, three months to 2023-12-31−$226.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-25, accession 0001641172-25-000632. Derived: 12-month figure less the 9-month figure.Report this figure(1.5)Operating income, Q1 FY2024, three months to 2024-03-31−$1.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-14, accession 0001641172-25-010254.Report this figure(2.9)Operating income, Q2 FY2024, three months to 2024-06-30−$2.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-13, accession 0001493152-25-011885.Report this figure0.8Operating income, Q3 FY2024, three months to 2024-09-30$778.5k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001493152-25-021894.Report this figure2.3Operating income, Q4 FY2024, three months to 2024-12-31$2.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-24, accession 0001493152-26-012352. Derived: 12-month figure less the 9-month figure.Report this figure0.8Operating income, Q1 FY2025, three months to 2025-03-31$825.5k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001493152-26-022479.Report this figure2.5Operating income, Q2 FY2025, three months to 2025-06-30$2.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001493152-26-037176.Report this figure2.9Operating income, Q3 FY2025, three months to 2025-09-30$2.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001493152-25-021894.Report this figure1.1Operating income, Q4 FY2025, three months to 2025-12-31$1.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-24, accession 0001493152-26-012352. Derived: 12-month figure less the 9-month figure.Report this figure2.6Operating income, Q1 FY2026, three months to 2026-03-31$2.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001493152-26-022479.Report this figure1.8Operating income, Q2 FY2026, three months to 2026-06-30$1.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001493152-26-037176.Report this figure
Interest expense$m0.2Interest expense, Q3 FY2023, three months to 2023-09-30$188.3k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-12, accession 0001493152-24-044737.Report this figure0.3Interest expense, Q4 FY2023, three months to 2023-12-31$287.5k. XBRL concept us-gaap:InterestExpense. 10-K filed 2025-03-25, accession 0001641172-25-000632. Derived: 12-month figure less the 9-month figure.Report this figure0.3Interest expense, Q1 FY2024, three months to 2024-03-31$267.3k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-14, accession 0001641172-25-010254.Report this figure0.6Interest expense, Q2 FY2024, three months to 2024-06-30$644.3k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-13, accession 0001493152-25-011885.Report this figure0.9Interest expense, Q3 FY2024, three months to 2024-09-30$927.6k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-12, accession 0001493152-25-021894.Report this figure1.3Interest expense, Q4 FY2024, three months to 2024-12-31$1.3m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-24, accession 0001493152-26-012352. Derived: 12-month figure less the 9-month figure.Report this figure1.3Interest expense, Q1 FY2025, three months to 2025-03-31$1.3m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-12, accession 0001493152-26-022479.Report this figure1.8Interest expense, Q2 FY2025, three months to 2025-06-30$1.8m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-11, accession 0001493152-26-037176.Report this figure1.8Interest expense, Q3 FY2025, three months to 2025-09-30$1.8m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-12, accession 0001493152-25-021894.Report this figure1.8Interest expense, Q4 FY2025, three months to 2025-12-31$1.8m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-24, accession 0001493152-26-012352. Derived: 12-month figure less the 9-month figure.Report this figure1.8Interest expense, Q1 FY2026, three months to 2026-03-31$1.8m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-12, accession 0001493152-26-022479.Report this figure1.8Interest expense, Q2 FY2026, three months to 2026-06-30$1.8m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-11, accession 0001493152-26-037176.Report this figure
Income tax$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$m(1.1)Net income, Q3 FY2023, three months to 2023-09-30−$1.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0001493152-24-044737.Report this figure(0.2)Net income, Q4 FY2023, three months to 2023-12-31−$237.2k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-25, accession 0001641172-25-000632. Derived: 12-month figure less the 9-month figure.Report this figure(1.8)Net income, Q1 FY2024, three months to 2024-03-31−$1.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-14, accession 0001641172-25-010254.Report this figure(3.5)Net income, Q2 FY2024, three months to 2024-06-30−$3.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-13, accession 0001493152-25-011885.Report this figure(2.9)Net income, Q3 FY2024, three months to 2024-09-30−$2.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001493152-25-021894.Report this figure(1.5)Net income, Q4 FY2024, three months to 2024-12-31−$1.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-24, accession 0001493152-26-012352. Derived: 12-month figure less the 9-month figure.Report this figure(3.5)Net income, Q1 FY2025, three months to 2025-03-31−$3.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-12, accession 0001493152-26-022479.Report this figure(2.0)Net income, Q2 FY2025, three months to 2025-06-30−$2.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001493152-26-037176.Report this figure(30.4)Net income, Q3 FY2025, three months to 2025-09-30−$30.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001493152-25-021894.Report this figure(1.6)Net income, Q4 FY2025, three months to 2025-12-31−$1.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-24, accession 0001493152-26-012352. Derived: 12-month figure less the 9-month figure.Report this figure0.5Net income, Q1 FY2026, three months to 2026-03-31$459.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-12, accession 0001493152-26-022479.Report this figure(0.5)Net income, Q2 FY2026, three months to 2026-06-30−$452.9k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001493152-26-037176.Report this figure
Diluted EPS$ per share(0.13)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0001493152-24-044737.Report this figurenot reported(0.21)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-14, accession 0001641172-25-010254.Report this figure(0.41)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-13, accession 0001493152-25-011885.Report this figure(0.34)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001493152-25-021894.Report this figurenot reported(0.41)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001493152-26-022479.Report this figure(0.23)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001493152-26-037176.Report this figure(3.40)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$3.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001493152-25-021894.Report this figurenot reported0.05Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001493152-26-022479.Report this figure(0.05)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001493152-26-037176.Report this figure
Basic EPS$ per share(0.13)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0001493152-24-044737.Report this figurenot reported(0.21)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-14, accession 0001641172-25-010254.Report this figure(0.41)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.41 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-13, accession 0001493152-25-011885.Report this figure(0.34)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001493152-25-021894.Report this figurenot reported(0.41)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.41 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001493152-26-022479.Report this figure(0.23)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.23 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001493152-26-037176.Report this figure(3.52)Basic EPS, Q3 FY2025, three months to 2025-09-30−$3.52 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001493152-25-021894.Report this figurenot reported0.05Basic EPS, Q1 FY2026, three months to 2026-03-31$0.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001493152-26-022479.Report this figure(0.05)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001493152-26-037176.Report this figure

Balance sheet

Cash and equivalents$15.4m, Q2 FY2026
Long-term debt$46.5m, Q2 FY2026
Shareholders' equity$7.9m, Q2 FY2026
Sanara MedTech Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m6.2Cash and equivalents, Q3 FY2023, at 2023-09-30$6.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-13, accession 0001493152-23-040475.Report this figure5.1Cash and equivalents, FY2023, at 2023-12-31$5.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-25, accession 0001641172-25-000632.Report this figure2.8Cash and equivalents, Q1 FY2024, at 2024-03-31$2.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-13, accession 0001493152-24-018880.Report this figure6.2Cash and equivalents, Q2 FY2024, at 2024-06-30$6.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-12, accession 0001493152-24-031254.Report this figure16.3Cash and equivalents, Q3 FY2024, at 2024-09-30$16.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0001493152-24-044737.Report this figure15.9Cash and equivalents, FY2024, at 2024-12-31$15.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-24, accession 0001493152-26-012352.Report this figure20.7Cash and equivalents, Q1 FY2025, at 2025-03-31$20.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-14, accession 0001641172-25-010254.Report this figure17.0Cash and equivalents, Q2 FY2025, at 2025-06-30$17.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-13, accession 0001493152-25-011885.Report this figure14.9Cash and equivalents, Q3 FY2025, at 2025-09-30$14.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001493152-25-021894.Report this figure16.6Cash and equivalents, FY2025, at 2025-12-31$16.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001493152-26-037176.Report this figure13.6Cash and equivalents, Q1 FY2026, at 2026-03-31$13.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0001493152-26-022479.Report this figure15.4Cash and equivalents, Q2 FY2026, at 2026-06-30$15.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001493152-26-037176.Report this figure
Current assets$m19.4Current assets, Q3 FY2023, at 2023-09-30$19.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-13, accession 0001493152-23-040475.Report this figure19.0Current assets, FY2023, at 2023-12-31$19.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-25, accession 0001641172-25-000632.Report this figure17.2Current assets, Q1 FY2024, at 2024-03-31$17.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-13, accession 0001493152-24-018880.Report this figure20.8Current assets, Q2 FY2024, at 2024-06-30$20.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-12, accession 0001493152-24-031254.Report this figure31.9Current assets, Q3 FY2024, at 2024-09-30$31.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0001493152-24-044737.Report this figure33.3Current assets, FY2024, at 2024-12-31$33.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-24, accession 0001493152-26-012352.Report this figure36.8Current assets, Q1 FY2025, at 2025-03-31$36.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-14, accession 0001641172-25-010254.Report this figure33.7Current assets, Q2 FY2025, at 2025-06-30$33.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-13, accession 0001493152-25-011885.Report this figure31.2Current assets, Q3 FY2025, at 2025-09-30$31.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001493152-25-021894.Report this figure33.5Current assets, FY2025, at 2025-12-31$33.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001493152-26-037176.Report this figure31.2Current assets, Q1 FY2026, at 2026-03-31$31.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-12, accession 0001493152-26-022479.Report this figure32.2Current assets, Q2 FY2026, at 2026-06-30$32.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001493152-26-037176.Report this figure
Total assets$m73.9Total assets, Q3 FY2023, at 2023-09-30$73.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0001493152-24-044737.Report this figure73.9Total assets, FY2023, at 2023-12-31$73.9m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-25, accession 0001641172-25-000632.Report this figure70.9Total assets, Q1 FY2024, at 2024-03-31$70.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-13, accession 0001493152-24-018880.Report this figure73.4Total assets, Q2 FY2024, at 2024-06-30$73.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-12, accession 0001493152-24-031254.Report this figure88.5Total assets, Q3 FY2024, at 2024-09-30$88.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0001493152-24-044737.Report this figure88.1Total assets, FY2024, at 2024-12-31$88.1m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-24, accession 0001493152-26-012352.Report this figure96.4Total assets, Q1 FY2025, at 2025-03-31$96.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-14, accession 0001641172-25-010254.Report this figure98.8Total assets, Q2 FY2025, at 2025-06-30$98.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-13, accession 0001493152-25-011885.Report this figure71.1Total assets, Q3 FY2025, at 2025-09-30$71.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001493152-25-021894.Report this figure72.9Total assets, FY2025, at 2025-12-31$72.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001493152-26-037176.Report this figure69.3Total assets, Q1 FY2026, at 2026-03-31$69.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-12, accession 0001493152-26-022479.Report this figure69.1Total assets, Q2 FY2026, at 2026-06-30$69.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001493152-26-037176.Report this figure
Current liabilities$m13.2Current liabilities, Q3 FY2023, at 2023-09-30$13.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-13, accession 0001493152-23-040475.Report this figure13.8Current liabilities, FY2023, at 2023-12-31$13.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-25, accession 0001641172-25-000632.Report this figure12.7Current liabilities, Q1 FY2024, at 2024-03-31$12.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-13, accession 0001493152-24-018880.Report this figure11.6Current liabilities, Q2 FY2024, at 2024-06-30$11.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-12, accession 0001493152-24-031254.Report this figure14.3Current liabilities, Q3 FY2024, at 2024-09-30$14.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0001493152-24-044737.Report this figure15.3Current liabilities, FY2024, at 2024-12-31$15.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-24, accession 0001493152-26-012352.Report this figure13.3Current liabilities, Q1 FY2025, at 2025-03-31$13.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-14, accession 0001641172-25-010254.Report this figure14.9Current liabilities, Q2 FY2025, at 2025-06-30$14.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-13, accession 0001493152-25-011885.Report this figure17.4Current liabilities, Q3 FY2025, at 2025-09-30$17.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001493152-25-021894.Report this figure18.6Current liabilities, FY2025, at 2025-12-31$18.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001493152-26-037176.Report this figure13.7Current liabilities, Q1 FY2026, at 2026-03-31$13.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-12, accession 0001493152-26-022479.Report this figure12.5Current liabilities, Q2 FY2026, at 2026-06-30$12.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001493152-26-037176.Report this figure
Total liabilities$m31.4Total liabilities, Q3 FY2023, at 2023-09-30$31.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-13, accession 0001493152-23-040475.Report this figure29.3Total liabilities, FY2023, at 2023-12-31$29.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-25, accession 0001641172-25-000632.Report this figure27.9Total liabilities, Q1 FY2024, at 2024-03-31$27.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-13, accession 0001493152-24-018880.Report this figure32.0Total liabilities, Q2 FY2024, at 2024-06-30$32.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-12, accession 0001493152-24-031254.Report this figure49.1Total liabilities, Q3 FY2024, at 2024-09-30$49.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0001493152-24-044737.Report this figure49.2Total liabilities, FY2024, at 2024-12-31$49.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-24, accession 0001493152-26-012352.Report this figure59.7Total liabilities, Q1 FY2025, at 2025-03-31$59.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-14, accession 0001641172-25-010254.Report this figure63.4Total liabilities, Q2 FY2025, at 2025-06-30$63.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-13, accession 0001493152-25-011885.Report this figure64.9Total liabilities, Q3 FY2025, at 2025-09-30$64.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001493152-25-021894.Report this figure67.0Total liabilities, FY2025, at 2025-12-31$67.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001493152-26-037176.Report this figure62.3Total liabilities, Q1 FY2026, at 2026-03-31$62.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-12, accession 0001493152-26-022479.Report this figure61.2Total liabilities, Q2 FY2026, at 2026-06-30$61.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001493152-26-037176.Report this figure
Long-term debt$m9.5Long-term debt, Q3 FY2023, at 2023-09-30$9.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-11-13, accession 0001493152-23-040475.Report this figure9.1Long-term debt, FY2023, at 2023-12-31$9.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-03-25, accession 0001641172-25-000632.Report this figure8.8Long-term debt, Q1 FY2024, at 2024-03-31$8.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-13, accession 0001493152-24-018880.Report this figure14.4Long-term debt, Q2 FY2024, at 2024-06-30$14.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-12, accession 0001493152-24-031254.Report this figure30.1Long-term debt, Q3 FY2024, at 2024-09-30$30.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-12, accession 0001493152-24-044737.Report this figure30.7Long-term debt, FY2024, at 2024-12-31$30.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-03-24, accession 0001493152-26-012352.Report this figure43.4Long-term debt, Q1 FY2025, at 2025-03-31$43.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-14, accession 0001641172-25-010254.Report this figure44.2Long-term debt, Q2 FY2025, at 2025-06-30$44.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-13, accession 0001493152-25-011885.Report this figure45.1Long-term debt, Q3 FY2025, at 2025-09-30$45.1m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-12, accession 0001493152-25-021894.Report this figure46.0Long-term debt, FY2025, at 2025-12-31$46.0m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-11, accession 0001493152-26-037176.Report this figure46.2Long-term debt, Q1 FY2026, at 2026-03-31$46.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-12, accession 0001493152-26-022479.Report this figure46.5Long-term debt, Q2 FY2026, at 2026-06-30$46.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-11, accession 0001493152-26-037176.Report this figure
Current portion of debt$m0.2Current portion of debt, Q3 FY2023, at 2023-09-30$232.1k. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2023-11-13, accession 0001493152-23-040475.Report this figure0.6Current portion of debt, FY2023, at 2023-12-31$580.4k. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2025-03-25, accession 0001641172-25-000632.Report this figure0.9Current portion of debt, Q1 FY2024, at 2024-03-31$928.6k. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2024-05-13, accession 0001493152-24-018880.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m44.3Shareholders' equity, Q3 FY2023, at 2023-09-30$44.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2023-11-13, accession 0001493152-23-040475.Report this figure44.8Shareholders' equity, FY2023, at 2023-12-31$44.8m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-03-25, accession 0001641172-25-000632.Report this figure43.3Shareholders' equity, Q1 FY2024, at 2024-03-31$43.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-05-13, accession 0001493152-24-018880.Report this figure41.7Shareholders' equity, Q2 FY2024, at 2024-06-30$41.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-08-12, accession 0001493152-24-031254.Report this figure39.8Shareholders' equity, Q3 FY2024, at 2024-09-30$39.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0001493152-24-044737.Report this figure39.4Shareholders' equity, FY2024, at 2024-12-31$39.4m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-24, accession 0001493152-26-012352.Report this figure36.7Shareholders' equity, Q1 FY2025, at 2025-03-31$36.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-14, accession 0001641172-25-010254.Report this figure35.4Shareholders' equity, Q2 FY2025, at 2025-06-30$35.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-13, accession 0001493152-25-011885.Report this figure6.1Shareholders' equity, Q3 FY2025, at 2025-09-30$6.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001493152-25-021894.Report this figure5.9Shareholders' equity, FY2025, at 2025-12-31$5.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001493152-26-037176.Report this figure7.0Shareholders' equity, Q1 FY2026, at 2026-03-31$7.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-12, accession 0001493152-26-022479.Report this figure7.9Shareholders' equity, Q2 FY2026, at 2026-06-30$7.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001493152-26-037176.Report this figure

Cash flow

Operating cash flow$2.0m, Q2 FY2026
Capital expenditure$5.3k, Q2 FY2026
Sanara MedTech Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k1,064Operating cash flow, Q3 FY2023, three months to 2023-09-30$1.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0001493152-24-044737. Derived: 9-month figure less the 6-month figure.Report this figure(849)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$848.5k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-25, accession 0001641172-25-000632. Derived: 12-month figure less the 9-month figure.Report this figure(1,594)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$1.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-14, accession 0001641172-25-010254.Report this figure(1,412)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$1.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-13, accession 0001493152-25-011885. Derived: 6-month figure less the 3-month figure.Report this figure2,050Operating cash flow, Q3 FY2024, three months to 2024-09-30$2.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001493152-25-021894. Derived: 9-month figure less the 6-month figure.Report this figure932Operating cash flow, Q4 FY2024, three months to 2024-12-31$932.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-24, accession 0001493152-26-012352. Derived: 12-month figure less the 9-month figure.Report this figure(1,999)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$2.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001493152-26-022479.Report this figure2,664Operating cash flow, Q2 FY2025, three months to 2025-06-30$2.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001493152-26-037176. Derived: 6-month figure less the 3-month figure.Report this figure2,176Operating cash flow, Q3 FY2025, three months to 2025-09-30$2.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001493152-25-021894. Derived: 9-month figure less the 6-month figure.Report this figure3,945Operating cash flow, Q4 FY2025, three months to 2025-12-31$3.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-24, accession 0001493152-26-012352. Derived: 12-month figure less the 9-month figure.Report this figure(2,465)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$2.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001493152-26-022479.Report this figure2,038Operating cash flow, Q2 FY2026, three months to 2026-06-30$2.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001493152-26-037176. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$k170Capital expenditure, Q3 FY2023, three months to 2023-09-30$170.3k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0001493152-24-044737. Derived: 9-month figure less the 6-month figure.Report this figure54.3Capital expenditure, Q4 FY2023, three months to 2023-12-31$54.3k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-25, accession 0001641172-25-000632. Derived: 12-month figure less the 9-month figure.Report this figure65.8Capital expenditure, Q1 FY2024, three months to 2024-03-31$65.8k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-14, accession 0001641172-25-010254.Report this figure58.8Capital expenditure, Q2 FY2024, three months to 2024-06-30$58.8k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-13, accession 0001493152-25-011885. Derived: 6-month figure less the 3-month figure.Report this figure9.1Capital expenditure, Q3 FY2024, three months to 2024-09-30$9.1k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001493152-25-021894. Derived: 9-month figure less the 6-month figure.Report this figure72.2Capital expenditure, Q4 FY2024, three months to 2024-12-31$72.2k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-24, accession 0001493152-26-012352. Derived: 12-month figure less the 9-month figure.Report this figure1,723Capital expenditure, Q1 FY2025, three months to 2025-03-31$1.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001493152-26-022479.Report this figure1,761Capital expenditure, Q2 FY2025, three months to 2025-06-30$1.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001493152-26-037176. Derived: 6-month figure less the 3-month figure.Report this figure1,059Capital expenditure, Q3 FY2025, three months to 2025-09-30$1.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001493152-25-021894. Derived: 9-month figure less the 6-month figure.Report this figure82.2Capital expenditure, Q4 FY2025, three months to 2025-12-31$82.2k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-24, accession 0001493152-26-012352. Derived: 12-month figure less the 9-month figure.Report this figure43.8Capital expenditure, Q1 FY2026, three months to 2026-03-31$43.8k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001493152-26-022479.Report this figure5.3Capital expenditure, Q2 FY2026, three months to 2026-06-30$5.3k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001493152-26-037176. Derived: 6-month figure less the 3-month figure.Report this figure
Dividends paid$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)8.66m, Q2 FY2026
Sanara MedTech Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)k shares8,107Diluted shares (weighted), Q3 FY2022, three months to 2022-09-308,107,261 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-13, accession 0001493152-23-040475.Report this figure8,174Diluted shares (weighted), Q1 FY2023, three months to 2023-03-318,173,784 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-13, accession 0001493152-24-018880.Report this figure8,226Diluted shares (weighted), Q2 FY2023, three months to 2023-06-308,226,271 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-12, accession 0001493152-24-031254.Report this figure8,332Diluted shares (weighted), Q3 FY2023, three months to 2023-09-308,332,341 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0001493152-24-044737.Report this figure8,420Diluted shares (weighted), Q1 FY2024, three months to 2024-03-318,419,528 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-14, accession 0001641172-25-010254.Report this figure8,469Diluted shares (weighted), Q2 FY2024, three months to 2024-06-308,468,835 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-13, accession 0001493152-25-011885.Report this figure8,517Diluted shares (weighted), Q3 FY2024, three months to 2024-09-308,517,381 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001493152-25-021894.Report this figure8,570Diluted shares (weighted), Q1 FY2025, three months to 2025-03-318,570,104 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001493152-26-022479.Report this figure8,927Diluted shares (weighted), Q2 FY2025, three months to 2025-06-308,927,060 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001493152-26-037176.Report this figure8,941Diluted shares (weighted), Q3 FY2025, three months to 2025-09-308,940,734 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001493152-25-021894.Report this figure8,986Diluted shares (weighted), Q1 FY2026, three months to 2026-03-318,985,866 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001493152-26-022479.Report this figure8,663Diluted shares (weighted), Q2 FY2026, three months to 2026-06-308,662,671 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001493152-26-037176.Report this figure

Shares outstanding: 9.19mShares outstanding, period not labelled, at 2026-08-079,188,035 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-11, accession 0001493152-26-037176.Report this figure at Aug 7, 2026, from the cover of the 10-Q filed Aug 11, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. Listed shows no prices and gives no investment advice.